What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Alan B. Cantor focuses on Cancer research, Internal medicine, Surgery, Cancer and Genetics.
His Cancer research research integrates issues from Epidermal growth factor receptor, Lung cancer, Loss of heterozygosity, Tumor suppressor gene and STAT3.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology.
Alan B. Cantor combines subjects such as Relative risk and Sentinel lymph node, Breast cancer with his study of Surgery.
His work in the fields of Ovarian cancer overlaps with other areas such as Geriatrics.
His study in Transcription factor is interdisciplinary in nature, drawing from both Transcription, Regulation of gene expression and Haematopoiesis.
His most cited work include:
- Lymphatic mapping and sentinel node biopsy in the patient with breast cancer (1155 citations)
- Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma (612 citations)
- Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A (604 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Surgery, Oncology, Cancer research and Pathology.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Endocrinology.
The concepts of his Surgery study are interwoven with issues in Sentinel lymph node, Breast cancer and Metastasis.
His Oncology research incorporates elements of Survival rate, Gemcitabine and Prostate cancer.
He focuses mostly in the field of Cancer research, narrowing it down to topics relating to Lung cancer and, in certain cases, Respiratory disease.
Many of his studies on Pathology apply to Tumor progression as well.
He most often published in these fields:
- Internal medicine (28.65%)
- Surgery (18.54%)
- Oncology (17.70%)
What were the highlights of his more recent work (between 2014-2021)?
- Transcription factor (14.33%)
- Cell biology (10.11%)
- RUNX1 (3.93%)
In recent papers he was focusing on the following fields of study:
Alan B. Cantor mainly focuses on Transcription factor, Cell biology, RUNX1, Cancer research and Biochemistry.
Genetics and Gene are inextricably linked to his Transcription factor research.
As a part of the same scientific study, he usually deals with the Genetics, concentrating on Genome-wide association study and frequently concerns with Phenotype.
His research in Cell biology intersects with topics in Chromatin, Chromatin immunoprecipitation, Erythropoietin and Zinc finger.
His studies in Cancer research integrate themes in fields like Platelet disorder, Downregulation and upregulation, Ribosome biogenesis and Stem cell, BMI1.
His work on Amino acid, mTORC1, Leucine and Cell type as part of general Biochemistry research is frequently linked to Amino acid transporter, thereby connecting diverse disciplines of science.
Between 2014 and 2021, his most popular works were:
- Sirolimus for progressive neurofibromatosis type 1–associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study (72 citations)
- Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1 (43 citations)
- The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability (36 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
The scientist’s investigation covers issues in Biochemistry, Internal medicine, Intervention, Oncology and Neurofibromatosis.
Alan B. Cantor combines topics linked to Magnetic resonance imaging with his work on Internal medicine.
He interconnects Surgery, Sirolimus, Gastroenterology, Toxicity and Neurofibromatoses in the investigation of issues within Magnetic resonance imaging.
His work carried out in the field of Intervention brings together such families of science as Psychological intervention, Adverse effect, Quality of life, Physical therapy and Anthropometry.
His research in Psychological intervention focuses on subjects like Risk factor, which are connected to Cancer.
His Oncology research is multidisciplinary, relying on both Clinical endpoint, PI3K/AKT/mTOR pathway, Combination therapy and Malignant peripheral nerve sheath tumor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
